| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 2 securities · passive | ||||||
|
Rani Therapeutics Holdings, Inc.
13G/A
0753018100
|
4.4% |
5/15/2026
Event 3/27/2026
|
||||
|
Generation Bio Co.
13G/A
GBIO · 37148K209
|
6.3% |
11/14/2025
Event 9/30/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.